Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Health providers decide the safest way to begin the treatment
On June 24, 2026, Novo Nordisk, a global leader in diabetes and obesity treatments, officially launched its flagship weight-loss drug Wegovy (Semaglutide) in India
We probably need to think of these drugs in the context of multiple disease treatment in tandem with obesity, such as those with metabolic syndrome, CVD, CKD, and MASLD
This evolving competition is expected to drive innovation in areas such as delivery devices, patient adherence tools, and real-world clinical data generation
Popcorn Many dietitians consider popcorn a great whole-grain snack for those with type 2 diabetes
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 25.59
US$ 27.59
US$ 26.15
US$ 26.78
US$ 22.88
US$ 24.59
US$ 28.72
